1 – 3 of 3
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2004
- Overexpression of cyclin E protein is associated with specific mutation types in the p53 gene and poor survival in human breast cancer
- Skin toxicity as a risk factor for major infections in breast cancer patients treated with docetaxel
- 2002
- A population-based study on the first forty-eight breast cancer patients receiving trastuzumab (Herceptin (R)) on a named patient basis in Sweden